Robert Fee

Conference Coverage
Bevacizumab-awwb Safe, Effective Among Patients With Metastatic Colorectal Cancer
06/04/2022
Study examines real-world effectiveness and safety of Bevacizumab-awwb, the first FDA-approved biosimilar to Avastin, among patients with metastatic colorectal cancer.
Study examines real-world effectiveness and safety of Bevacizumab-awwb, the first FDA-approved biosimilar to Avastin, among patients with metastatic colorectal cancer.
Study examines real-world...
06/04/2022
Journal of Clinical Pathways
Conference Coverage
The Financial Impact of Biosimilar Adoption in the Oncology Care Model
06/05/2022
In a study presented at the 2022 ASCO Annual Meeting, researchers examined the utilization and the financial impact of biosimilar adoption in The US Oncology Network Over a six-month period.
In a study presented at the 2022 ASCO Annual Meeting, researchers examined the utilization and the financial impact of biosimilar adoption in The US Oncology Network Over a six-month period.
In a study presented at the 2022...
06/05/2022
Journal of Clinical Pathways
Conference Coverage
Real-world Treatment Patterns for Patients With Metastatic Castration-Resistant Prostate Cancer
06/06/2022
Although numerous treatments with different mechanisms of action are approved for metastatic castration-resistant prostate cancer (mCRPC), the sequencing for management of these patients has been evolving post availability of trials.
Although numerous treatments with different mechanisms of action are approved for metastatic castration-resistant prostate cancer (mCRPC), the sequencing for management of these patients has been evolving post availability of trials.
Although numerous treatments...
06/06/2022
Journal of Clinical Pathways
Conference Coverage
Real-World Survival Outcomes With PARP Inhibitor Maintenance in Advanced Ovarian Cancer
06/05/2022
Study examines patient records over five years to determine real-world efficacy benefits of PARPi therapy vs active surveillance confirms the efficacy benefits that have been demonstrated in randomized clinical trials of PARPis vs placebo.
Study examines patient records over five years to determine real-world efficacy benefits of PARPi therapy vs active surveillance confirms the efficacy benefits that have been demonstrated in randomized clinical trials of PARPis vs placebo.
Study examines patient records...
06/05/2022
Journal of Clinical Pathways
Conference Coverage
Clinical Implications of Tumor-Based Next-generation Sequencing in Ovarian Cancer
06/04/2022
A study presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting assessed the clinical relevance of tumor-based next-generation sequencing (tbNGS) in a large cohort of patients with high-grade epithelial ovarian...
A study presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting assessed the clinical relevance of tumor-based next-generation sequencing (tbNGS) in a large cohort of patients with high-grade epithelial ovarian...
A study presented at the 2022...
06/04/2022
Journal of Clinical Pathways
Conference Coverage
Treatment Patterns and Efficacy of Bruton Tyrosine Kinase Inhibitors in Patients With MCL
06/09/2022
Retrospective multicenter chart review conducted in the Cardinal Health Oncology Provider Extended Network assessed treatment patterns and associated outcomes in patients with MCL who were treated with BTKi.
Retrospective multicenter chart review conducted in the Cardinal Health Oncology Provider Extended Network assessed treatment patterns and associated outcomes in patients with MCL who were treated with BTKi.
Retrospective multicenter chart...
06/09/2022
Journal of Clinical Pathways
Conference Coverage
Case Study Assesses Self-Reported Financial Difficulties Among Patients With Multiple Myeloma or Chronic Lymphocytic Leukemia
06/09/2022
A study presented by the Alliance for Clinical Trials in Oncology at the 2022 ASCO Annual Meeting confirms that many patients with blood cancers experience financial difficulties.
A study presented by the Alliance for Clinical Trials in Oncology at the 2022 ASCO Annual Meeting confirms that many patients with blood cancers experience financial difficulties.
A study presented by the...
06/09/2022
Journal of Clinical Pathways
Conference Coverage
Study Examines Charges Associated With US Hospital Payer-Specific Negotiated Mammography
06/09/2022
A cross-sectional study of US acute care and critical access hospitals presented at the 2022 ASCO Annual Meeting examined the factors associated with payer-negotiated mammography charges.
A cross-sectional study of US acute care and critical access hospitals presented at the 2022 ASCO Annual Meeting examined the factors associated with payer-negotiated mammography charges.
A cross-sectional study of US...
06/09/2022
Journal of Clinical Pathways
News
ASCO Establishes Center for Equity, Diversity, and Inclusion
04/22/2022
The American Society of Clinical Oncology (ASCO) recently created the ASCO Center for Equity, Diversity, and Inclusion, which is designed to promote equity, diversity, and inclusion (EDI) goals across the organization and throughout the wider...
The American Society of Clinical Oncology (ASCO) recently created the ASCO Center for Equity, Diversity, and Inclusion, which is designed to promote equity, diversity, and inclusion (EDI) goals across the organization and throughout the wider...
The American Society of Clinical...
04/22/2022
Journal of Clinical Pathways
Conference Coverage
Bringing the Benefits of At-home Programs to Patients With Cancer Who Live in Rural Areas
06/09/2022
Researchers show how patients with cancer who are living in rural communities can receive the benefits of oncology hospital at home programs in a case study from the 2022 ASCO Annual Meeting.
Researchers show how patients with cancer who are living in rural communities can receive the benefits of oncology hospital at home programs in a case study from the 2022 ASCO Annual Meeting.
Researchers show how patients...
06/09/2022
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use